health
The Promise of Next-Gen Drugs, ETPharma
Explore how new cholesterol-lowering therapies, including PCSK9 inhibitors and oral options, are changing the landscape of cardiovascular disease prevention in India, addressing the unmet needs of patients with elevated cholesterol.
New Delhi: Over two decades, names such as Rosuvas, Atorlip and a host of other oral pills have become household names for millions of patients living with elevated cholesterol. The common thread binding these brands is the most prescribed breakthrou... [7687 chars]
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18